The NF‐κB signaling pathway is crucial in lung cancer progression, and studies have reported that NAT10 promotes NF‐κB signaling pathway activity in lung cancer, thereby promoting lung cancer progression.123. The gene discussed is NAT10; the disease is lung carcinoma.